Health
Second study testing Covid-19 antibody drug has a setback – Deccan Herald
For the second time, a study testing an experimental antibody drug for Covid-19 has been paused to investigate a possible safety issue in hospitalised patients….
For the second time, a study testing an experimental antibody drug for Covid-19 has been paused to investigate a possible safety issue in hospitalised patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavourable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Business17 hours ago2 Low Cost Active ASX ETFs to consider
-
General21 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’
-
General20 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate